mice for predetermined periods (1, 2, 4 , and 8 h) at 75 rpm and 37 °C. Then, each sample was centrifuged at 1500 rpm for 5 min at each time point. The absorbance of the supernatant was measured at 540 nm using a Varioskan Flash multimode reader (Thermo, USA). PBS and the RBC suspension treated with 0.2% Triton X-100 were used as negative and positive control groups, respectively. The hemolysis percentage was calculated according to the following formula:
Hemolysis (%) = (A sample -A PBS / (A Triton-100 -A PBS )) × 100%.
5.
In Vitro Drug Release. The in vitro DOX release behavior of LT/DOX NPs and PLT/DOX NPs was evaluated. Aliquots (1 mL, at equivalent dose of DOX 100 μg) of NP dispersions were loaded into dialysis bags (7 kDa molecular weight cutoff). Each dialysis bag was immersed in PBS (50 mL, 7. In Vitro Cytotoxicity Analysis. The cytotoxicities of different formulations were evaluated in B16F10 cells by the MTT assay. Briefly, B16F10 cells were seeded in 96-well plates (3 × 10 3 cells/well) and incubated for 12 h at 37 °C and in a 5% CO 2 atmosphere. The culture medium was removed, and then, free DOX, LT NPs, PLT NPs, LT/DOX NPs or PLT/DOX NPs were added at a series of concentrations and incubated with the cells for an additional 48 h. Then, 20 μL of MTT solution (5 mg/mL in PBS) was added to each well, and the plates were incubated for 4 h at 37 °C and in a 5% CO 2 atmosphere. Finally, the culture medium was removed, and the residue was dissolved in 150 μL of DMSO per well. The absorbance of each group was measured by a Varioskan Flash multimode reader (Thermo, USA) at 570 nm. The cell viability (%) was calculated by the following formula: Cell viability (%) = A test -A DMSO / A control -A DMSO × 100.
Cellular Uptake and Intracellular Delivery in B16F10 Cells.
To investigate the cellular internalization of different micelles, uptake assays using SA-overexpressing B16F10 cells and HepG2 cells and SA-underexpressing COS-7 cells as the recipient cells were conducted. We conducted the cell uptake assays in pH 7.4 and pH 6.5 serum-free media. Briefly, B16F10 cells were seeded in 6-well plates (3 × 10 5 per well) and grown overnight before incubation with DiDloaded NPs. After incubation with LT/DiD NPs, PLT/DiD NPs, PLT-Fru/DiD NPs or PLT-SA/DiD NPs in pH 6.5 or pH 7.4 medium for 2 h, the cells were harvested and washed with PBS. After centrifugation (3000 rpm for 3 min), the cells were resuspended in PBS (300 μL), and the mean fluorescence of DiD in individual cells was quantified by a flow cytometer (FL4 675 nm, Beckman
Coulter, Inc., USA, Cytomics FC 500).
We also used CLSM to detect the fluorescence signals of different cells treated with different preparations. Three types of cells were cultured on coverslips in 6-well plates (2× 10 5 per well) as described above. To verify the interaction between PBA and SA residues, free SA (500 μM) was pre-incubated with micelle suspensions for 2 h, and the mixture was added to the cells. Meanwhile, PBA (500 μM) was pre-incubated with cells for 1 h prior to the addition of the DOX-loaded NP suspensions to the cells, respectively. The cells were incubated for 2 h, washed with PBS (pH 7.4) for three times, and fixed in 4% (m/v) paraformaldehyde solution for 10 min. Then, the cells were dried under an air stream and stained with 0.5% 4′,6-diamidino-2-phenylindole (DAPI) for 4 min.
After being washed three times with PBS, the cells were mounted (Vectashield antifade mounting medium H-1000) and observed by CLSM (DOX: E x = 488 nm, E m = 555 nm; DAPI: E x = 340 nm, E m = 488 nm; Olympus Co., Ltd, FV1000, Japan).
To track intracellular NP delivery, B16F10 cells and HepG2 cells were stained with
LysoTracker Red DND-99 (E x = 577 nm, E m = 590 nm) 30 min before the end of the cellular uptake assay and then photographed by CLSM using the staining and mounting method described above. After 48 h of incubation, the migrated or invaded cells were fixed in 4% (m/v) paraformaldehyde solution for 10 min and stained with crystal violet. Finally, the bottoms of the chambers were viewed under an inverted microscope in five predetermined fields. Then, the crystal violet was eluted by a 33% acetic acid solution, and the absorbance was measured at 570 nm using a
Varioskan Flash multimode reader.
11.
In vitro MMP-9 Expression Detection. In brief, B16F10 cells were seeded in 6-well plates (1.5 × 10 5 per well) individually and grown overnight before incubating with NPs. Afterwards cells were treated with PBS, LMWH, LT NPs, PLT NPs, LT/DOX NPs or PLT/DOX NPs (at an equivalent dose of 100 μg mL -1 PLT NPs) for 30 h. Then, the culture medium of each group was analyzed using mouse MMP-9 ELISA kit. Moreover, MMP-9 in cells was detected by Western blot assay.
Cells in each well were harvested and mixed with 50 μL cell lysate buffer (Beyotime, China).
Samples were centrifuged at 4°C and 13,000 rpm for 15 min, and the supernatant was collected as
Western blot assay samples. Each sample was then separated by 6% SDS-PAGE, and followed by transferring to polyvinylidene difluoride membranes. Finally, samples were incubated with antibody.
HRP-labeled mouse anti-goat secondary antibody was added and measured using a Bio-Rad ChemiDoc MP System.
Adherence of Platelets to Tumor Cells In Vitro and Implantation in Lung Tissue of B16F10 Cells
In Vivo. Platelet-rich plasma (PRP) was obtained from male C57BL/6 mice and washed with PBS and then labeled with 5 μM calcein AM for 20 min using a previously reported method. [2] Meanwhile, the B16F10 cells were seeded in 6-well plates and grown to approximately 80% confluency. Then, the medium was changed, and a total of 1 × 10were added to each well. After treatment with PBS (as a control), free LMWH, LT NPs or PLT NPs, the cells were washed three times with PBS. Finally, the cells were lysed with DMSO, and the fluorescence signal was detected by a fluorospectro-photometer at E x = 490 nm and E m = 515 nm.
To investigate the efficacy of NPs against CTC implantation, C57BL/6 mice were pretreated with PBS, free LMWH, LT NPs or PLT NPs (60 mg kg -1 ) 30 min in advance. Meanwhile, the B16F10 cells were stained with carboxyfluorescein succinimidyl ester (CFSE) (20 μM, 37 °C, 15 min). Then, 2 × 10 5 CFSE-labeled B16F10 cells were injected into mice via the tail vein. The lungs were harvested 30 min after cell injection and frozen section analysis was performed. Cell nuclei were stained with DAPI. The distribution of tumor cells in the lungs was observed by CLSM (the fluorescence signal of CFSE was detected at E x = 496 nm and E m = 516 nm). We also tested another dosage regimen to investigate the anti-metastatic effect of DOX-loaded NPs. A total of 2 × 10 5 B16F10 cells in 100 μL of PBS were injected into the C57BL/6 mice via the tail vein to generate a lung metastatic mouse model of melanoma. On the 4 th day, the mice were randomly divided into 6 groups and administered PBS, free DOX, free LMWH, blank LT NPs (60 mg kg -1 ), LT/DOX NPs or PLT/DOX NPs (at an equivalent dose of 2.5 mg kg -1 DOX) every 2 days for a total of 4 times. At day 19, the mice were sacrificed, and the lungs were collected and imaged.
In vitro E-cadherin and N-cadherin Expression
Then, the lung tissues were subjected to H&E staining.
19. Statistical Analysis. Data were expressed as the means ± standard deviations (SD). Statistical analysis was performed by one-way ANOVA or Student's t-test. Significant differences between groups are indicated by *p＜0.05, **p＜0.01 and ***p＜0.001. Table S3 . Pharmacokinetic parameters of DOX after intravenous administration of free DOX, LT/DOX NPs, PLT/DOX NPs or PLT-Fru/DOX NPs at a dose of 3 mg kg -1 DOX.( data represent mean data ± SD, n=3) 
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